These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18188867)

  • 21. [Role of neuroendocrine cells in prostate cancer progression].
    Sciarra A; Innocenzi M; Ravaziol M; Minisola F; Alfarone A; Cattarino S; Panebianco V; Buonocore V; Gentile V; Di Silverio F
    Urologia; 2011; 78(2):126-31. PubMed ID: 21574145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid hormone-related peptide: expression in prostate cancer bone metastases.
    Bryden AA; Islam S; Freemont AJ; Shanks JH; George NJ; Clarke NW
    Prostate Cancer Prostatic Dis; 2002; 5(1):59-62. PubMed ID: 15195132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer.
    Ishida E; Nakamura M; Shimada K; Tasaki M; Konishi N
    Pathobiology; 2009; 76(1):30-8. PubMed ID: 19188748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive activation of gp130 leads to neuroendocrine differentiation in vitro and in vivo.
    Palmer J; Ernst M; Hammacher A; Hertzog PJ
    Prostate; 2005 Feb; 62(3):282-9. PubMed ID: 15389784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
    Kasper S
    J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
    Yuan TC; Veeramani S; Lin MF
    Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship of neuroendocrine differentiation to biological behavior of prostate cancer].
    Wu XL; Huang KT; Chen W; Chen L; Dong L; Yu ZX
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):472-5. PubMed ID: 19567097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmented expression of chromogranin A and serotonin in peri-malignant benign prostate epithelium as compared to adenocarcinoma.
    Sion-Vardy N; Tzikinovsky A; Bolotyn A; Segal S; Fishman D
    Pathol Res Pract; 2004; 200(7-8):493-9. PubMed ID: 15462496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).
    Zhu Y; Liu C; Cui Y; Nadiminty N; Lou W; Gao AC
    Prostate; 2014 Aug; 74(11):1086-94. PubMed ID: 24819501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An allograft model of androgen independent prostatic neuroendocrine carcinoma derived from a large probasin promoter-T antigen transgenic mouse line.
    Masumori N; Tsuchiya K; Tu WH; Lee C; Kasper S; Tsukamoto T; Shappell SB; Matusik RJ
    J Urol; 2004 Jan; 171(1):439-42. PubMed ID: 14665950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical and ultrastructural features of neuroendocrine differentiated carcinomas of the prostate: an immunoelectron microscopic study.
    Hirano D; Jike T; Okada Y; Minei S; Sugimoto S; Yamaguchi K; Yoshikawa T; Hachiya T; Yoshida T; Takimoto Y
    Ultrastruct Pathol; 2005; 29(5):367-75. PubMed ID: 16257863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of neuroendocrine markers in non-small cell lung cancer.
    Sørhaug S; Steinshamn S; Haaverstad R; Nordrum IS; Martinsen TC; Waldum HL
    APMIS; 2007 Feb; 115(2):152-63. PubMed ID: 17295682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
    Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
    Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of neuroendocrine tumor cells on proliferation in prostatic carcinoma.
    Grobholz R; Griebe M; Sauer CG; Michel MS; Trojan L; Bleyl U
    Hum Pathol; 2005 May; 36(5):562-70. PubMed ID: 15948124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
    Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J
    Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma induces neuroendocrine-like differentiation of human prostate basal-epithelial cells.
    Untergasser G; Plas E; Pfister G; Heinrich E; Berger P
    Prostate; 2005 Sep; 64(4):419-29. PubMed ID: 15800938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.
    Fixemer T; Remberger K; Bonkhoff H
    Prostate; 2002 Oct; 53(2):118-23. PubMed ID: 12242726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
    Sainio M; Visakorpi T; Tolonen T; Ilvesaro J; Bova GS
    Pathol Res Pract; 2018 Jun; 214(6):848-856. PubMed ID: 29728311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings?
    Angelsen A; Syversen U; Haugen OA; Stridsberg M; Mjølnerød OK; Waldum HL
    Prostate; 1997 Jan; 30(1):1-6. PubMed ID: 9018329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.